Are hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?

Digestive and Liver Disease

Volumn 34, Issue 1, 2002, Pages 53-58

  Di Stefano, R ^b   Ferraro, D ^b   Bonura, C ^b   Pizzolanti, G ^b   Lo Iacono, O ^a   Di Marco, V ^a   Craxii A ^a  

^a Institute of Legal Medicine   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Chronic hepatitis; Cirrhosis; Hepatitis C virus; Hepatitis G virus; TT virus

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; INFECTION RISK; ITALY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; MALE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; RISK FACTOR; TORQUE TENO VIRUS;

ADULT; ALANINE TRANSAMINASE; DNA VIRUS INFECTIONS; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TORQUE TENO VIRUS;

EID: 0036186442     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80060-3     Document Type: Article

References (54)

1. Etiology of chronic hepatitis in France: Predominant role of hepatitis C virus
2. Nonalcoholic steatohepatitis
3. Prevalence of and risk factors for hepatic steatosis in Northern Italy
4. Non-alcoholic steatohepatitis (NASH): A disease of emerging identify and importance
5. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
6. Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C viruses
7. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests
8. The cloning and clinical implications of HGV and HG-BV-C
9. GBV-C/HGV: A new virus within the Flaviviridae and its clinical implications
10. Histologic spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type C hepatitis
11. Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: Failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction
12. Hepatitis G virus infection in American patients with cryptogenic cirrhosis: No evidence for liver replication
13. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation
14. GB virus infection in acute and chronic cryptogenic liver disease
15. Chronic cryptogenic hepatitis in childhood is unrelated to hepatitis G virus
16. Absence of hepatitis G virus within liver tissue of patients undergoing liver transplantation for cryptogenic cirrhosis
17. Prevalence of GB virus-C hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease
18. GB virus C/Hepatitis G virus infection in Saudi Arabian blood donors and patients with cryptogenic hepatitis
19. Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis
20. HGV infection in patients with acute hepatitis of known and unknown aetiology
21. Insignificant role of hepatitis G virus infection in patients with liver enzyme elevations of unknown etiology
22. Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy
23. Coeliac disease hidden by cryptogenic hypertransaminasaemia
24. Natural course of HGV infection in haemophiliacs
25. Long, benign course of hepatitis G virus infection
26. New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism
27. Effect of interferon on a nonenveloped DNA virus (TT virus) associated with acute and chronic hepatitis of unknown etiology
28. High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: Identification of G4 isolates in Italy
29. TT virus (TTV) is not associated with acute sporadic hepatitis
30. Genotypes of TT virus (TTV) compared between liver disease patients and healthy individuals using a new PCR system capable of differentiating 1a and 1b types from others
31. Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan
32. High prevalence of TT virus infection in Japanese patients with liver diseases and in blood donors
33. Prevalence and clinical characteristics of TT virus (TTV) in patients with sporadic acute hepatitis of unknown aetiology
34. Determination of antibodies to TT virus (TTV) and application to blood donors and patients with post-transfusion non-A to G hepatitis in Japan
35. Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels
36. TT virus infection in patients with chronic hepatitis B or C: Influence on clinical, histological and virological features
37. Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients
38. TT virus infection in patients with chronic hepatitis C virus infection - Effect of primers, prevalence, and clinical significance
39. TT virus infection in patients with chronic liver disease of unknown aetiology
40. Detection of TT virus sequences in children with liver disease of unknown aetiology
41. Detection of TT virus DNA in patients with liver disease and recipients of liver transplant
42. TT virus as a human pathogen: Significance and problems
43. TT virus infection during chronic hepatitis C
44. Clinical implications of TT virus superinfection in patients with chronic hepatitis C
45. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis
46. Classification of chronic hepatitis: A need for reassessment
47. Single step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction
48. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions
49. Sequence heterogeneity within the 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes
50. Molecular cloning and disease association of Hepatitis G virus: A transfusion-transmissible agent
51. Analysis of TTV in liver tissue with hepato-cellular carcinoma
52. TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology
53. Molecular epidemiology of TT virus in Italy and phylogenesis of viral isolates from subjects at different risk for parenteral exposure
54. Prevalence of TT viral DNA in Italian blood donors with and without elevated serum ALT levels: Molecular characterization of viral DNA isolates